Cite
Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.
MLA
Azoulay, David, et al. “Bortezomib-Induced Peripheral Neuropathy Is Related to Altered Levels of Brain-Derived Neurotrophic Factor in the Peripheral Blood of Patients with Multiple Myeloma.” British Journal of Haematology, vol. 164, no. 3, Feb. 2014, pp. 454–56. EBSCOhost, https://doi.org/10.1111/bjh.12624.
APA
Azoulay, D., Lavie, D., Horowitz, N., Suriu, C., Gatt, M. E., Akria, L., Perlman, R., Braester, A., & Ben-Yehuda, D. (2014). Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma. British Journal of Haematology, 164(3), 454–456. https://doi.org/10.1111/bjh.12624
Chicago
Azoulay, David, David Lavie, Netanel Horowitz, Celia Suriu, Moshe E Gatt, Luiza Akria, Riki Perlman, Andrei Braester, and Dina Ben-Yehuda. 2014. “Bortezomib-Induced Peripheral Neuropathy Is Related to Altered Levels of Brain-Derived Neurotrophic Factor in the Peripheral Blood of Patients with Multiple Myeloma.” British Journal of Haematology 164 (3): 454–56. doi:10.1111/bjh.12624.